IMMX
Immix Biopharma (IMMX)
$46
About Immix Biopharma (IMMX)
Immix Biopharma, Inc. operates as a biopharmaceutical company that engages in the development of therapies for cancer and inflammatory diseases. The company was founded by Ilya Rachman, Sean Senn, and Vladimir Torchilin in 2012 and is headquartered in Los Angeles, CA.
Details
Daily high
$1.54
Daily low
$1.36
Price at open
$1.37
52 Week High
$7.75
52 Week Low
$1.26
Market cap
37.9M
Dividend yield
0.00%
Volume
227,996
Avg. volume
150,713
P/E ratio
-1.60
Immix Biopharma News
Details
Daily high
$1.54
Daily low
$1.36
Price at open
$1.37
52 Week High
$7.75
52 Week Low
$1.26
Market cap
37.9M
Dividend yield
0.00%
Volume
227,996
Avg. volume
150,713
P/E ratio
-1.60